ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 644961 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 644961; 2) Community: the network communities that were significantly associated with the response to NSC 644961; 3) Molecule: the relationships between components within communities and NSC 644961; 4) MDR: the compounds that were significantly associated with the NSC 644961.

NSC Compound Enrichment Correlation
NSC 724631 4,11-dihydroxy-1-[4-[[2-hydroxy-1-(hydroxymethyl)-1-methylet hyl]-mino]butyl]-1H-naphtho[2,3-f]indole-5,10-dione 0.0385067071027345 -0.24746709
NSC 736179 1,2-Dithiolan-3-yl-N-(3'-methoxyestra-1',3',5'(10')-triene-1 7'b-yl)pentanamide 0.0385067071027345 -0.092914081
NSC 759216 (3-(4-bromophenyl)-5-(1,3-diphenyl-1H-pyrazol-4-yl)-4,5-dihydropyrazol-1-yl)(4-methoxyphenyl)methanone 0.0385067071027345 0.082772539
NSC 320846 Batracylin, Daniquidone 0.0385203205529756 0.47556384
NSC 366739 CHAETOGLOBOSIN A 0.0385203205529756 -0.10297323
NSC 529108 4-Fluoro-D,L-tryptophan 0.0385203205529756 0.25404917
NSC 58905 9H-Purine, 9-(2-chloroethyl)-6-[(phenylmethyl)thio]- (9CI) 0.0385203205529756 0.15014352
NSC 609815 2-Benzoylaminobenzamide, N-thiazol-2-yl- 0.0385203205529756 0.028519097
NSC 610456 Camptothecin Derivative 0.0385203205529756 0.68607564
NSC 617582 Null 0.0385203205529756 0.37702581
Total:65  Current:50    [First] [Prev] [Next] [Last]